Mirum Pharmaceuticals, Inc. Quarterly Operating Lease, Payments in USD from Q2 2019 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Mirum Pharmaceuticals, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q2 2019 to Q1 2024.
  • Mirum Pharmaceuticals, Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $289K, a 10.3% increase year-over-year.
  • Mirum Pharmaceuticals, Inc. annual Operating Lease, Payments for 2023 was $1.08M, a 18.4% increase from 2022.
  • Mirum Pharmaceuticals, Inc. annual Operating Lease, Payments for 2022 was $911K, a 5.44% increase from 2021.
  • Mirum Pharmaceuticals, Inc. annual Operating Lease, Payments for 2021 was $864K, a 50% increase from 2020.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $289K +$27K +10.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q1 2023 $262K +$43K +19.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q1 2022 $219K +$7K +3.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q1 2021 $212K +$105K +98.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q1 2020 $107K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q2 2019 $0 Apr 1, 2019 Jun 30, 2019 10-Q 2019-08-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.